Almirall SA (ALM.MC) Company Profile | Reuters.com
Edition:
United States

Profile: Almirall SA (ALM.MC)

ALM.MC on Madrid SE C.A.T.S.

12.45EUR
24 Jun 2016
Change (% chg)

-- (--)
Prev Close
€12.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
240,204
52-wk High
€19.36
52-wk Low
€12.23

Almirall SA is a Spain-based company principally engaged in the research, development, storage and distribution of pharmaceutical products. The Company’s range of products include a variety of drugs for the treatment of diseases in such therapeutic areas as asthma, chronic obstructive pulmonary disease (COPD), gastrointestinal disorders, psoriasis, as well as other dermatologic conditions. In addition, the Company is involved in the manufacturing and distribution of cosmetics, chemical products, biotechnology and diagnostics; research on chemical and pharmaceutical products; as well as the acquisition and management of land properties. The Company operates in Europe and Mexico and Canada, in The Americas. In January 2013, the Company completed the acquisition of Aqua Pharmaceuticals.

Company Address

Almirall SA

Ronda General Mitre, 151
BARCELONA   BAR   08022
P: +34932.913000
F: +34932.913681

Company Web Links